Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Evvy

Explore full profile

Evvy - Vaginal Microbiome Testing & Care

New York City, United StatesFounded 2020Health Tech & Medtech
Valuation $100–250M Last recorded · 2026
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Evvy and the history behind them.

About Evvy

Evvy is a pioneering startup in the women's health sector, offering the first-ever at-home vaginal microbiome test. This test uses advanced metagenomic sequencing, a method that analyzes the genetic material of all the microorganisms in a sample, to provide detailed insights into the vaginal health of its users. The company collaborates with top-tier OB-GYNs and researchers from prestigious institutions like UCSF, Cleveland Clinic, Stanford, and Harvard to ensure the accuracy and reliability of its tests.

Read full description

Evvy's primary clients are individuals with vaginas who are seeking to understand and improve their vaginal health. The company operates in the women's health and wellness market, focusing on empowering its users with actionable information about their vaginal microbiome. This is a crucial aspect of health that has been historically overlooked, and Evvy aims to close this gender health gap by discovering and leveraging biomarkers—biological indicators of health conditions—in the female body.

The business model of Evvy is direct-to-consumer (DTC). Customers can order the vaginal health test kit online, collect their sample at home, and send it back to Evvy for analysis. The company then provides a detailed report that explains the state of the user's vaginal microbiome and offers personalized recommendations for improving their health. While the information provided is for wellness purposes and not a substitute for medical advice, it empowers users to make informed decisions about their health.

Evvy generates revenue through the sale of these test kits. By offering a subscription model, they can also ensure recurring revenue as users may opt for regular testing to monitor their vaginal health over time.

In summary, Evvy is revolutionizing women's health by providing accessible, science-backed insights into the vaginal microbiome, helping individuals make informed decisions about their wellness.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
New York City, United States
Employees
62
Open positions
4
Dealroom signal
77.8/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Fertility, Biotechnology, Women's Health, Health Diagnostics, Microbiome, Femtech, Digital Therapeutics, Hard Tech, Woman Founder
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2c

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Sep 2023 $14M $56M General Catalyst · Human Ventures · Left Lane Capital · Ingeborg Investments ↗
SEED✓Equity / VC Jul 2021 $5M $20M BoxGroup · Human Ventures · G9 Ventures · BBG Ventures —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Evvy website traffic

Latest recorded traffic for Evvy is 330K monthly website visits, down 45.9% over the last three months. Evvy's team grew 3.3% over the past year.

Latest monthly visits330K 3-month web change-45.9% 1-year team growth+3.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

Series A5 investors entered at this stage

  • Left Lane Capital
  • Ingeborg Investments
  • Amboy Street Ventures (ASV)
  • RH Capital
  • LabCorp
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States95.6%
🇬🇧 United Kingdom2.2%
🇨🇦 Canada2.2%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Evvy on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Evvy’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.